The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
possible, until they get a slant from the FDA as to the route to go down. This will not be overnight. Until then, this stock is crazy cheap
There is no immediate need to fund raise, they are sufficiently capitalised, so no fire sale raise
Until then, we expect this to be back in the 20's once the dust has settled
nm
perfect, thank you MOTIF and the FDA
planned for tomorrow, watch this space
Will be able to explain the issues in hand
nm
on some of those American sites
for a first start
Sit back with a position bought between 5 and 6 watch it rise to 50/60 in short time, 3 months or less
Life changing for lots of us
We now know that this will be approved, not today but in the next 3 months or so
In what’s called a complete response letter, the FDA indicated additional data would be required “to further evaluate the risk for liver toxicity” ------ before granting approval.
Rubbish, coal is making a huge comeback
http://www.timesnews.net/Business/2018/05/21/Is-coal-making-a-comeback
Countries in Africa need this
MOTIF is very different to IMM. The FDA said IMM Lupus didn't work, different here, the FDA said they need more information
Clearly it works as it passed staged 3, clearly this will be approved, once MOTIF submit further information
Its a no brainer at this level, even if they have to raise more money to get there
Interesting one
Funds have to sell as the Company's market cap has fallen below the threshold that a fund can, is allowed to hold
Its now a small cap, this is where the smaller investor makes money
no brainer to average here
This will get approved, albeit another 3 months or so
from 5p to £1.00
with an RNS explaining the issues
Main point is that we passed Phase 3 - how on earth can we pass phase 3 if their was a liver toxicity issue
Someone enlighten me please
was the statement that "we need to raise"